Sanofi-Synthelabo
Pharmaceuticals
France
France
Current Rank | 360 |
Prior Rank | N/A |
Executive 1 | J.-f. Dehecq, Chairman, Board of Directors |
Executive 2 | H. Guerin, Vive-Chairman & Chief Executive Officer |
Revenue (US$ Millions) | $5,387 |
Revenue Growth (%) | 20.89% |
Net Income (US$ Millions) | $629 |
Earnings Per Share (US$) | $0.86 |
Total Equity (US$ Millions) | $3,603 |
Profit Margin (%) | 11.68% |
Debt To Equity Ratio (%) | 0.27% |